Azimuth Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $17.9M | Sell |
62,637
-1,093
| -2% | -$281K | 0.77% | 34 |
|
|
2021
Q4 | $17.6M | Sell |
63,730
-1,676
| -3% | -$425K | 0.71% | 45 |
|
|
2021
Q3 | $15.1M | Sell |
65,406
-1,563
| -2% | -$386K | 0.65% | 53 |
|
|
2021
Q2 | $15.4M | Sell |
66,969
-1,054
| -2% | -$212K | 0.66% | 48 |
|
|
2021
Q1 | $12.7M | Sell |
68,023
-1,503
| -2% | -$294K | 0.6% | 61 |
|
|
2020
Q4 | $11.7M | Buy |
69,526
+377
| +0.5% | +$56.3K | 0.58% | 63 |
|
|
2020
Q3 | $10.2M | Sell |
69,149
-1,627
| -2% | -$252K | 0.6% | 60 |
|
|
2020
Q2 | $11.6M | Sell |
70,776
-3,937
| -5% | -$604K | 0.74% | 49 |
|
|
2020
Q1 | $10.4M | Sell |
74,713
-2,669
| -3% | -$367K | 0.78% | 43 |
|
|
2019
Q4 | $10.2M | Sell |
77,382
-897
| -1% | -$104K | 0.62% | 61 |
|
|
2019
Q3 | $8.75M | Sell |
78,279
-473
| -0.6% | -$52.7K | 0.57% | 69 |
|
|
2019
Q2 | $8.72M | Sell |
78,752
-197
| -0.2% | -$23.2K | 0.58% | 65 |
|
|
2019
Q1 | $10.2M | Sell |
78,949
-3,073
| -4% | -$374K | 0.69% | 46 |
|
|
2018
Q4 | $9.49M | Sell |
82,022
-1,397
| -2% | -$156K | 0.73% | 43 |
|
|
2018
Q3 | $8.95M | Sell |
83,419
-1,722
| -2% | -$172K | 0.6% | 63 |
|
|
2018
Q2 | $7.26M | Sell |
85,141
-1,190
| -1% | -$97.7K | 0.52% | 76 |
|
|
2018
Q1 | $6.68M | Sell |
86,331
-529
| -0.6% | -$42.6K | 0.49% | 79 |
|
|
2017
Q4 | $7.34M | Sell |
86,860
-1,246
| -1% | -$106K | 0.53% | 74 |
|
|
2017
Q3 | $7.54M | Buy |
88,106
+7,691
| +10% | +$631K | 0.56% | 67 |
|
|
2017
Q2 | $6.62M | Buy |
80,415
+4
| +0% | +$326 | 0.52% | 74 |
|
|
2017
Q1 | $6.76M | Sell |
80,411
-496
| -0.6% | -$39.7K | 0.54% | 69 |
|
|
2016
Q4 | $5.95M | Buy |
80,907
+977
| +1% | +$72.8K | 0.51% | 72 |
|
|
2016
Q3 | $6.42M | Sell |
79,930
-446
| -0.6% | -$35.7K | 0.56% | 66 |
|
|
2016
Q2 | $6.33M | Buy |
80,376
+255
| +0.3% | +$19.2K | 0.57% | 63 |
|
|
2016
Q1 | $5.77M | Sell |
80,121
-96
| -0.1% | -$7.26K | 0.55% | 70 |
|
|
2015
Q4 | $6.76M | Sell |
80,217
-22
| -0% | -$1.83K | 0.66% | 52 |
|
|
2015
Q3 | $6.71M | Sell |
80,239
-421
| -0.5% | -$35.5K | 0.7% | 46 |
|
|
2015
Q2 | $6.73M | Sell |
80,660
-2,014
| -2% | -$153K | 0.65% | 47 |
|
|
2015
Q1 | $6.01M | Sell |
82,674
-25,151
| -23% | -$1.79M | 0.58% | 54 |
|
|
2014
Q4 | $7.44M | Buy |
107,825
+2,559
| +2% | +$173K | 0.77% | 39 |
|
|
2014
Q3 | $6.83M | Buy |
105,266
+300
| +0.3% | +$19K | 0.75% | 40 |
|
|
2014
Q2 | $6.53M | Buy |
104,966
+2,442
| +2% | +$146K | 0.73% | 40 |
|
|
2014
Q1 | $6.04M | Buy |
102,524
+4,555
| +5% | +$254K | 0.73% | 43 |
|
|
2013
Q4 | $5M | Buy |
97,969
+905
| +0.9% | +$45.3K | 0.6% | 54 |
|
|
2013
Q3 | $4.88M | Buy |
97,064
+39,973
| +70% | +$2.09M | 0.67% | 46 |
|
|
2013
Q2 | $2.8M | Buy |
+57,091
| New | +$3.11M | 0.49% | 76 |
|
Other funds holding LLY
Azimuth Capital Management's LLY Position: Q1 2022 in Review
Azimuth Capital Management reduced its Eli Lilly (LLY) stake by 1.7% in Q1 2022, selling an estimated $281K and leaving 62,637 shares worth $17.9M. The position accounts for 0.77% of the portfolio, ranked #34.
Azimuth Capital Management first reported a position in LLY in Q2 2013 and has held it in 36 quarters since. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.
- Azimuth Capital Management held 62,637 shares of Eli Lilly worth $17.9M as of Q1 2022.
- Azimuth Capital Management sold 1,093 Eli Lilly shares in Q1 2022, an estimated $281K.
- Eli Lilly made up 0.77% of Azimuth Capital Management's portfolio in Q1 2022, its #34 holding.
- Azimuth Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 36 quarters since.
- 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.
Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.